Creatine Muscle Soreness Randomized Trial: What the Evidence Says

Quick Answer

Creatine Muscle Soreness Randomized Trial has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are systematic review, randomized trial, so conclusions should be framed as evidence-aware guidance rather than medical advice.

Key Takeaways

• This page is generated only from sources stored in the Migaku evidence knowledge base.
• Current evidence mix: 1 systematic review, 1 randomized trial.
• Claims should be interpreted with the source type, study design, population, and publication date in mind.
• This article is educational and does not replace care from a qualified clinician.

Evidence Map

What The Sources Report

• Clinically, EIMD is commonly reflected by delayed-onset muscle soreness (DOMS), elevated circulating creatine kinase (CK), and reduced neuromuscular performance. [Hou Chunlin (2026); evidence level 1]
• Massage and cryotherapy have been associated with reductions in DOMS and fatigue, and massage has also shown favourable effects on short-term recovery of performance. [Hou Chunlin (2026); evidence level 1]
• The importance of the timing of Cr administration is based on the assumption that exercise-induced physiological changes, such as increased hyperemia and altered transport dynamics, may optimize tissue absorption and storage. [Ben Maaoui Khouloud (2026); evidence level 2]
• Yet, evidence supporting specific timing strategies is restricted to a few chronic studies with conflicting findings. [Ben Maaoui Khouloud (2026); evidence level 2]

How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

Practical Interpretation

There is at least one systematic-review style source in the current set, so it deserves more weight than single-study evidence. There is trial evidence in the current set, but population and intervention details still matter. For creatine muscle soreness randomized trial, the next editorial step is to add more targeted sources and separate strong findings from early or indirect evidence.

Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

References

• Hou Chunlin (2026). Acute and Delayed Effects of Post-Exercise Recovery Strategies on Explosive Performance and Markers of Muscle Damage: A Systematic Review and Network Meta-Analysis. DOI: 10.3390/healthcare14101321. PMCID: PMC13206571. PMID: 42194413. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13206571/
• Ben Maaoui Khouloud (2026). Acute Creatine Ingestion Before Resistance Training Enhances Strength Performance More than Ingestion During or After Training: A Randomized Crossover Pilot Trial. DOI: 10.3390/nu18111789. PMCID: PMC13258838. PMID: 42280432. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13258838/

Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.